Trial intelligence / Profile preview

UFT/LV with or without PSK as adjuvant therapy for stage III colorectal cancer

NCT00497107Phase 3Unknown

Sponsor
Iwate Medical University
Start
Jul 2007
Modality
Recombinant Proteins and Enzymes, Microbiome-Derived Products
Countries
1
01

Overview

Phase 3, randomised, open-label trial of polysaccharide k in colorectal cancer (CRC), sponsored by Iwate Medical University. Status: unknown.

02

Drugs

polysaccharide k
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00497107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00497107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call